SCOTUS Preserves Mifepristone Telehealth Access as FDA Launches Safety Study
The Supreme Court allowed mifepristone to remain available via telehealth and mail while litigation continues. The FDA has also launched a six-month safety study of the abortion pill. Approximately 29% of U.S. abortions are now provided via telehealth.